- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04901507
Effects of an External Oral Irrigation Device on Patients With Dry Mouth
Study Overview
Detailed Description
Dry mouth causes difficulty with chewing, swallowing, speech, and increases the risk dental cavities. It also can cause discomfort in the mouth, and a loss of general quality of life. The oral irrigation device supplies a small amount of water to participant's mouth through a small tube that is placed in the corner of the mouth throughout the time participants wear it.
In this study, participants will be asked to:
- Visit the dental school clinic two (2) times for study visits.
- Wear the oral irrigation device as directed by the investigator.
- Keep notes at home.
- Answer survey questions during both dental visits about dry mouth symptoms.
- Give permission for the researchers to collect information about medications or health conditions that contribute to dry mouth from participant's medical records.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients who report xerostomia (dry mouth) and are diagnosed after testing with hypofunctioning salivary glands
Exclusion Criteria:
- Patient who after testing do not exhibit salivary hypofunction
- Children
- Patient with limited English proficiency
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The Voutia System
The Voutia System oral irrigation device
|
Participants will wear the Voutia System oral irrigation device continuously through the day and night, removing for cleaning and if otherwise necessary, but not for time extending beyond six-eight hours.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Oral Health Related Quality of Life (OHRQoL)
Time Frame: Baseline to 4 - 6 weeks
|
OHRQoL will be assess using the Oral Health Impact Profile (OHIP-14).
The OHIP-14 scores can range from 0 to 56 and are calculated by summing the ordinal values for the 14 items on the scale.
Higher OHIP-14 scores indicate worse and lower scores indicate better OHRQol
|
Baseline to 4 - 6 weeks
|
|
Change in Oral Health Related Quality of Life - Dry Mouth Specific (OHRQoL-XI)
Time Frame: Baseline to 4 - 6 weeks
|
OHRQoL-XI will be assessed using the Xerostomia Inventory (XI), an 11-item summated rating scale which combines the responses to 11 individual items into a single continuous scale score which represents the severity of chronic xerostomia.
Scores range from 11 to 55 with higher scores represent more severe symptoms.
|
Baseline to 4 - 6 weeks
|
|
Change in Oral Dryness
Time Frame: Baseline to 4 - 6 weeks
|
Clinical Oral Dryness Score (CODS) conducted during the clinical exam assesses ten key features of dry mouth and allocates one point for each feature.
The total score ranges from 0 to 10 with higher scores indicating more severe dry mouth.
|
Baseline to 4 - 6 weeks
|
|
Clinical Changes in Stimulated Saliva Flow
Time Frame: Baseline to 4 - 6 weeks
|
Data on routine stimulated saliva testing as performed as standard of care for patients suspected to have reduced salivary flow will be compared before and after use of the device.
|
Baseline to 4 - 6 weeks
|
|
Clinical Changes in Unstimulated Saliva Flow
Time Frame: Baseline to 4 - 6 weeks
|
Data on routine unstimulated saliva testing as performed as standard of care for patients suspected to have reduced salivary flow will be compared before and after use of the device.
|
Baseline to 4 - 6 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Susie Goolsby, DDS, MSHA, Virginia Commonwealth University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HM20021188
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Xerostomia
-
University of BrasiliaNot yet recruitingXerostomia Following Radiotherapy
-
Poznan University of Medical SciencesEnrolling by invitationXerostomia Due to Hyposecretion of Salivary GlandPoland
-
Bedford Hospital NHS TrustUnknownXerostomia | Xerostomia Due to Radiotherapy | Xerostomia Due to Hyposecretion of Salivary Gland
-
MeiraGTx, LLCActive, not recruitingRadiation-induced XerostomiaUnited States, Canada
-
Thomas KuhntVerband Deutscher DruckkammerzentrenTerminatedRadiation-induced XerostomiaGermany
-
Laboratoires CARILENEDERMSCAN-PHARMASCAN GROUP in charge of data analysisCompleted
-
Institute of Oncology LjubljanaUniversity Medical Centre Ljubljana; University of Ljubljana; Blood Transfusion...Not yet recruitingXerostomia Following RadiotherapySlovenia
-
Catholic University of the Sacred HeartSunstar Italiana SRL.CompletedXerostomia | Xerostomia Following RadiotherapyItaly
-
Qazvin University Of Medical SciencesImam Khomeini HospitalCompletedRadiation-Induced XerostomiaIran, Islamic Republic of
Clinical Trials on The Voutia System
-
Oslo University HospitalUnknownHypertension, Resistant to Conventional TherapyNorway
-
Assistance Publique Hopitaux De MarseilleUnknownGynecological SurgeryFrance
-
Acessa Health, Inc.CompletedUterine Fibroids | Uterine MyomasUnited States, Guatemala, Mexico
-
Lifetech Scientific (Shenzhen) Co., Ltd.RecruitingThoracoabdominal Aortic AneurysmsGermany
-
Zhejiang Zylox Medical Device Co., Ltd.Not yet recruitingPeripheral Artery DiseaseChina
-
Abbott Medical DevicesTerminated
-
Thinks Works, PBCSetting Scoliosis Straight Foundation; Nemours Children's HospitalRecruiting
-
National Institute on Aging (NIA)Completed
-
Zeltiq AestheticsCompleted
-
Lifetech Scientific (Shenzhen) Co., Ltd.Active, not recruiting